 Connection
Elizabeth Morris to Catalytic Domain
This is a "connection" page, showing publications Elizabeth Morris has written about Catalytic Domain.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.611 |
|
|
|
-
Acton OJ, Sheppard D, Kunzelmann S, Caswell SJ, Nans A, Burgess AJO, Kelly G, Morris ER, Rosenthal PB, Taylor IA. Platform-directed allostery and quaternary structure dynamics of SAMHD1 catalysis. Nat Commun. 2024 May 06; 15(1):3775.
Score: 0.195
-
Morris ER, Kunzelmann S, Caswell SJ, Purkiss AG, Kelly G, Taylor IA. Probing the Catalytic Mechanism and Inhibition of SAMHD1 Using the Differential Properties of Rp- and Sp-dNTPaS Diastereomers. Biochemistry. 2021 06 01; 60(21):1682-1698.
Score: 0.158
-
Morris ER, Caswell SJ, Kunzelmann S, Arnold LH, Purkiss AG, Kelly G, Taylor IA. Crystal structures of SAMHD1 inhibitor complexes reveal the mechanism of water-mediated dNTP hydrolysis. Nat Commun. 2020 06 23; 11(1):3165.
Score: 0.149
-
Youle RL, Lista MJ, Brudenell EL, Thompson B, Bouton C, Morris ER, Neil SJD, Swanson CM, Taylor IA. KHNYN is a manganese-dependent endoribonuclease required for ZAP-mediated antiviral restriction. Nucleic Acids Res. 2025 Nov 26; 53(22).
Score: 0.054
-
Flett FJ, Ruksenaite E, Armstrong LA, Bharati S, Carloni R, Morris ER, Mackay CL, Interthal H, Richardson JM. Structural basis for DNA 3'-end processing by human tyrosyl-DNA phosphodiesterase 1. Nat Commun. 2018 01 02; 9(1):24.
Score: 0.031
-
Wolkowicz UM, Morris ER, Robson M, Trubitsyna M, Richardson JM. Structural basis of Mos1 transposase inhibition by the anti-retroviral drug Raltegravir. ACS Chem Biol. 2014 Mar 21; 9(3):743-51.
Score: 0.024
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|